Natural Capsules liquidity ratios

Profitability Growth Credit Liquidity Working capital Dividend yield DuPont CAGR

Per cent unless marked ×

Tap a line for its trend	Last 12Mto Jun 2026	FY26Mar 2026	FY25Mar 2025

1.47×	—	—
1.03×	1.03×	1.30×
0.83×	0.83×	1.04×
0.2	0.2	0.7
4.1	4.1	29.6

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

NATCAPSUQ₹137.93

Natural Capsules Limited

· Pharma & Health

₹ CrorePeersNECLIFE AAREYDRUGS BALPHARMA ALPA KREBSBIO MEDICAMEQ MEDICO VINEETLABMcap ₹143 Cr

Profitability Growth Credit Liquidity Working Capital Yield Analysis DuPont

Ratios — % unless marked × 12 Months Ending	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Altman Z-Score (Other Equity as RE)	—	—	1.47
Current Ratio	1.30	1.03	1.03
Quick Ratio	1.04	0.83	0.83
Cash, Equiv & ST Investments	0.7	0.2	0.2
Working Capital	29.6	4.1	4.1

No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.